Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study. Issue 5 (May 2017)
- Record Type:
- Journal Article
- Title:
- Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio: a multicenter retrospective cohort study. Issue 5 (May 2017)
- Main Title:
- Prognostic value of preoperative 18F-FDG PET/CT in papillary thyroid cancer patients with a high metastatic lymph node ratio
- Authors:
- Kwon, Seong Young
Choi, Eun Kyoung
Kong, Eun Jung
Chong, Ari
Ha, Jung-Min
Chun, Kyung Ah
Cho, Ihn Ho
Bom, Hee-Seung
Min, Jung-Joon
Kim, Jahae
Song, Ho-Chun
O, Joo Hyun
Kim, Sung Hoon - Abstract:
- Abstract : Objective: Metastatic lymph node ratio (MLNR) is a known significant predictor of disease-free survival in differentiated thyroid cancer. The authors investigated the ability of preoperative fluorine-18 fluorodeoxyglucose ( 18 F-FDG) PET/CT to predict recurrence after surgery with radioactive iodine therapy considering MLNR. Patients and methods: A total of 274 patients who underwent preoperative PET/CT and surgery with radioactive iodine therapy were enrolled. The tumor-to-liver uptake ratio on PET/CT was calculated by dividing the maximum standardized uptake value of a primary lesion by the mean standardized uptake value of the normal liver. High 18 F-FDG uptake was defined as tumor-to-liver uptake ratio more than the median cutoff value (2.1). MLNR was calculated by dividing the number of metastatic lymph nodes (LNs) by the number of cervical LNs removed. A high MLNR was also defined as one more than a threshold value (0.4), identified by plotting Kaplan–Meier survival curves and comparing them using the log-rank test. The prognostic significances of clinicopathologic variables were analyzed. Results: Fifteen (5.5%) patients developed recurrence in the thyroid bed or in cervical LNs. Cox regression analysis showed that a high MLNR was significantly associated with a worse disease-free survival (odds ratio 6.95; 95% confidence interval: 2.36–20.47; P <0.001). A subgroup analysis of 70 patients with a high MLNR showed that only high 18 F-FDG uptake wasAbstract : Objective: Metastatic lymph node ratio (MLNR) is a known significant predictor of disease-free survival in differentiated thyroid cancer. The authors investigated the ability of preoperative fluorine-18 fluorodeoxyglucose ( 18 F-FDG) PET/CT to predict recurrence after surgery with radioactive iodine therapy considering MLNR. Patients and methods: A total of 274 patients who underwent preoperative PET/CT and surgery with radioactive iodine therapy were enrolled. The tumor-to-liver uptake ratio on PET/CT was calculated by dividing the maximum standardized uptake value of a primary lesion by the mean standardized uptake value of the normal liver. High 18 F-FDG uptake was defined as tumor-to-liver uptake ratio more than the median cutoff value (2.1). MLNR was calculated by dividing the number of metastatic lymph nodes (LNs) by the number of cervical LNs removed. A high MLNR was also defined as one more than a threshold value (0.4), identified by plotting Kaplan–Meier survival curves and comparing them using the log-rank test. The prognostic significances of clinicopathologic variables were analyzed. Results: Fifteen (5.5%) patients developed recurrence in the thyroid bed or in cervical LNs. Cox regression analysis showed that a high MLNR was significantly associated with a worse disease-free survival (odds ratio 6.95; 95% confidence interval: 2.36–20.47; P <0.001). A subgroup analysis of 70 patients with a high MLNR showed that only high 18 F-FDG uptake was significantly associated with a worse disease-free survival (odds ratio 5.77; 95% confidence interval: 1.22–27.16; P =0.027). Conclusion: High 18 F-FDG uptake of primary lesion on preoperative PET/CT has selective prognostic value according to the extent of metastatic LNs (MLNR>0.4). … (more)
- Is Part Of:
- Nuclear medicine communications. Volume 38:Issue 5(2017:May)
- Journal:
- Nuclear medicine communications
- Issue:
- Volume 38:Issue 5(2017:May)
- Issue Display:
- Volume 38, Issue 5 (2017)
- Year:
- 2017
- Volume:
- 38
- Issue:
- 5
- Issue Sort Value:
- 2017-0038-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2017-05
- Subjects:
- differentiated thyroid cancer -- lymph node ratio -- PET/CT -- prognosis -- radioactive iodine therapy
Nuclear medicine -- Periodicals
616.07575 - Journal URLs:
- http://journals.lww.com/nuclearmedicinecomm/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
http://www.lww.com/Product/0143-3636 ↗ - DOI:
- 10.1097/MNM.0000000000000657 ↗
- Languages:
- English
- ISSNs:
- 0143-3636
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6180.923000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 7898.xml